Infliximab trough levels are associated with transmural healing during maintenance treatment in pediatric Crohn's disease patients

被引：0
|
作者：
Kang, Ben [1 ]
Choi, So Yoon [2 ]
Choi, Young Ok [3 ]
Kim, Mi Jin [3 ]
Jeon, Tae Yeon [4 ]
Choe, Yon Ho [3 ]
机构：
[1] Kyungpook Natl Univ, Dept Pediat GI Hepatol, Med Ctr, Daegu, South Korea
[2] Inje Univ, Haeundae Paik Hosp, Dept Pediat GI Hepatol, Busan, South Korea
[3] Samsung Med Ctr, Dept Pediat GI Hepatol, Seoul, South Korea
[4] Seoul Med Ctr, Dept Radiol, Seoul, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
Crohn's disease; infliximab; pharmacokinetics; transmural healing; trough level;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OE-0634 (P
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [31] Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
    Bortlik, Martin
    Duricova, Dana
    Malickova, Karin
    Machkova, Nadezda
    Bouzkova, Eva
    Hrdlicka, Ludek
    Komarek, Arnost
    Lukas, Milan
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (09): : 736 - 743
  • [32] Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn's Disease
    Orts, Beatriz
    Gutierrez, Ana
    Madero, Lucia
    Sempere, Laura
    Frances, Ruben
    Zapater, Pedro
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [33] Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with biologics
    Testa, A.
    Rispo, A.
    Mainenti, P.
    Imperatore, N.
    De Palma, G. D.
    Rea, M.
    Maione, F.
    Nardone, O. M.
    Taranto, M. L.
    Castiglione, F.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S205 - S206
  • [34] CROSS-SECTIONAL EVALUATION OF TRANSMURAL HEALING IN PATIENTS WITH CROHN'S DISEASE ON MAINTENANCE TREATMENT WITH BIOLOGICS
    Rispo, A.
    Mainenti, P.
    Testa, A.
    Imperatore, N.
    De Palma, G. D.
    Rea, M.
    Maione, F.
    Nardone, O. M.
    Taranto, M. L.
    Castiglione, F.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E78 - E79
  • [35] Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
    Rutgeerts, P
    Diamond, RH
    Bala, M
    Olson, A
    Lichtenstein, GR
    Bao, WH
    Patel, K
    Wolf, DC
    Safdi, M
    Colombel, JF
    Lashner, B
    Hanauer, SB
    GASTROINTESTINAL ENDOSCOPY, 2006, 63 (03) : 433 - 442
  • [36] Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximab
    Orfanoudaki, E.
    Gazouli, M.
    Foteinogiannopoulou, K.
    Theodouraki, E.
    Legaki, E.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S330 - S331
  • [37] Subtherapeutic serum infliximab trough levels and complete mucosal healing are associated with sustained clinical remission after infliximab discontinuation in paediatric Crohn's disease patients
    Kang, B.
    Lee, K.
    Kim, K.
    Lee, J. H.
    Choe, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S45 - S46
  • [38] Crohn's Disease: Infliximab Trough Levels and CRP During Infliximab-Immunomodulator Combination Treatment Are Associated With Clinical Outcome After Immunomodulator Withdrawal
    Drobne, David
    Bossuyi, Peter J.
    Breynaen, Christine
    Vande Casteele, Niels
    Compemolle, Griel
    Juergens, Matthias
    Ballet, Vera
    Wollants, Willem-Jan
    Cleynen, Isabelle
    Rutgeens, Paul J.
    Vermeire, Severine
    Gils, Ann
    Van Assche, Gen A.
    GASTROENTEROLOGY, 2011, 140 (05) : S62 - S62
  • [39] SERUM ADALIMUMAB TROUGH LEVELS REQUIRED FOR ENDOSCOPIC MUCOSAL HEALING DURING MAINTENANCE THERAPY OF CROHN'S DISEASE
    Imaeda, Hirotsugu
    Nishino, Kyohei
    Ohno, Masashi
    Nishida, Atsushi
    Sugimoto, Mitsushige
    Andoh, Akira
    GASTROENTEROLOGY, 2017, 152 (05) : S393 - S393
  • [40] Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on adalimumab maintenance therapy
    Oh, E. H.
    Yoon, A. -R.
    Park, S. H.
    Kim, J.
    Ham, N.
    Song, E. M.
    Hwang, S. W.
    Park, S. H.
    Yang, D. -H.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S260 - S261
12345